Pharmacological analysis of inhomogeneous static magnetic field-induced antinociceptive action in the mouse

Bioelectromagnetics

Volumn 29, Issue 6, 2008, Pages 456-462

  Gyires, Klára ^a,c   Zádori, Zoltán S ^a   Rácz, Bernadette ^a   László, János ^b  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Mouse; Opioid antagonists; Static magnetic field; Writhing test

Indexed keywords

IRON ALLOYS; MAMMALS; NEODYMIUM ALLOYS; PH;

ANTINOCICEPTIVE EFFECT; FIELD-INDUCED; MOUSE; OPIOID ANTAGONIST; OPIOID RECEPTORS; OPIOIDS; RECEPTOR ANTAGONISTS; STATIC MAGNETIC FIELDS; WRITHING TEST; WRITHINGS;

ACETIC ACID;

ACETIC ACID; BETA FUNALTREXAMINE; DELTA OPIATE RECEPTOR; MU OPIATE RECEPTOR; NALOXONE; NALTRINDOLE; NORBINALTORPHIMINE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; MAGNET; MAGNETIC FIELD; MALE; MOUSE; NOCICEPTIVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; STATIC MAGNETIC FIELD; VISCERAL PAIN; WRITHING TEST;

MUS;

EID: 50249102634     PISSN: 01978462     EISSN: 1521186X     Source Type: Journal    
DOI: 10.1002/bem.20413     Document Type: Article

References (41)

1. Alfano AP, Taylor AG, Foresman PA, Dunkl PR, McConnell GG, Conaway MR, Gillies GT. 2001. Static magnetic fields for treatment of fibromyalgia: A randomized controlled trial. J Altern Complement Med 7(1):53-64.
2. Bao X, Shi Y, Huo X, Song T. 2006. A possible involvement of β-endorphin, substance P, and serotonin in rat analgesia induced by extremely low frequency magnetic field. Bioelectromagnetics 27(6):467-472.
3. Barr GA, Zadina JE. 1999. Maturation of endomorphin-2 in the dorsal horn of the medulla and spinal cord of the rat. Neuroreport 10:3857-3860.
4. Betancur C, Dell'Omo G, Alleva E. 1994. Magnetic field effects on stress-induced analgesia in mice: Modulation by light. Neurosci Lett 182(2):147-150.
5. Brack A, Rittner HL, Machelska H, Beschmann K, Sitte N, Schafer M. 2004. Mobilization of opioid-containing polymorphonuclear cells by hematopoetic growth factors and influence on inflammatory pain. Anesthesiology 101:204-211.
6. Brown CS, Ling FW, Wan JY, Pilla AA. 2002. Efficacy of static magnetic field therapy in chronic pelvic pain: A double-blind pilot study. Am J Obstet Gynecol 187(6):1581-1587.
7. Cabot PJ, Carter L, Gaiddon C, Zhang Q, Schafer M, Loeffler JP. 1997. Immune cell-derived β-endorphin. Production, release, and control of inflammatory pain in rats. J Clin Invest 100:142-148.
8. Del Seppia C, Luschi P, Ghione S, Crosio E, Choleris E, Papi F. 2000. Exposure to a hypogeomagnetic field or to oscillating magnetic fields similarly reduce stress-induced analgesia in C57 mice. Life Sci 66(14):1299-1306.
9. Del Seppia C, Mezzasalma L, Choleris E, Luschi P, Ghione S. 2003. Effects of magnetic field exposure on open field behaviour and nociceptive responses in mice. Behav Brain Res 144(1-2):1-9.
10. Gutstein HB, Bronstein DM, Akil H. 1992. β-Endorphin processing and cellular origins in rat spinal cord. Pain 51(2):241-247.
11. Gyires K, Torma Z. 1984. The use of writhing test in mice for screening different types of analgesics. Arch Int Pharmacodyn Ther 267:131-140.
12. Herz A. 1993. Opioids I-II. In: Handbook of experimental pharmacology, Vol. 104 I/II. Heidelberg: Springer Verlag.
13. Hinman MR, Ford J, Heyl H. 2002. Effects of static magnets on chronic knee pain and physical function: A double-blind study. Altern Ther Health Med 8(4):50-55.
14. Holcomb RR, Worthington WB, McCullough BA, McLean MJ. 2000. Static magnetic field therapy for pain in the abdomen and genitals. Pediatr Neurol 23(3):261-264.
15. International Programme on Chemical Safety. 1987. Environmental Health Criteria 69, Magnetic Fields. section: 1.4.2. available at http://www.inchem. org/documents/ehc/ehc/ehc69.htm.
16. Kangarlu A, Robitaille PML. 2000. Biological effects and health implications in magnetic resonance imaging. Concepts Magn Reson 12:321-359.
17. Kavaliers M, Ossenkopp KP. 1986. Magnetic field inhibition of morphine-induced analgesia and behavioral activity in mice: Evidence for involvement of calcium ions. Brain Res 379(1):30-38.
18. Kumar VS, Kumar DA, Kalaivani K, Gangadharan AC, Raju KV, Thejomoorthy P, Manohar BM, Puvanakrishnan R. 2005. Optimization of pulsed electromagnetic field therapy for management of arthritis in rats. Bioelectromagnetics 26(6):431-439.
19. László J, Gyires K. 2007. 3 T MR significantly inhibits pain in the writhing test in mise. Submitted for publication.
20. László J, Reiczigel J, Székely L, Gasparics A, Bogár I, Bors L, Rácz B, Gyires K. 2007. Optimization of static magnetic field parameters improves analgesic effect in mice. Bioelectromagnetics 28(8):615-627.
21. Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE. 1976. The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 197:517-532.
22. Martin LJ, Koren SA, Persinger MA. 2004. Influence of a complex magnetic field application in rats upon thermal nociceptive thresholds: The importance of polarity and timing. Internat J Neurosci 114(10):1259-1276.
23. Martin-Schild S, Zadina JE, Gerall AA, Vigh S, Kastin AJ. 1997. Localization of endomorphin-2-like immunoreactivity in the rat medulla and spinal cord. Peptides 18:1645-1649.
24. Mousa SA, Machelska H, Schafer M, Stein C. 2002. Immunohistochemical localization of endomorphin-1 and endomorphin-2 in immune cells and spinal cord in a model of inflammatory pain. J Neuroimmunol 126:5-15.
25. Pierce TL, Grahek MD, Wessendorf MV. 1998. Immunoreactivity for endomorphin-2 occurs in primary afferents in rats and monkey. Neuroreport 9:385-389.
26. Prato FS, Kavaliers M, Cullen AP, Thomas AW. 1997. Light-dependent and -independent behavioral effects of extremely low frequency magnetic fields in a land snail are consistent with a parametric resonance mechanism. Bioelectromagnetics 18:284-291.
27. Prato FS, Robertson JA, Desjardins D, Hensel J, Thomas AW. 2005. Daily repeated magnetic field shielding induces analgesia in CD-1 mice. Bioelectromagnetics 26(2):109-117.
28. Rittner HL, Brack A, Machelska H, Mousa SA, Bauer M, Schafer M. 2001. Opioid peptide-expressing leukocytes: Identification, recruitment, and simultaneously increasing inhibition of inflammatory pain. Anesthesiology 95:500-508.
29. Salvatore JR, Harrington J, Kummet T. 2003. Phase I clinical study of a static magnetic field combined with anti-neoplastic chemotherapy in the treatment of human malignancy: Initial safety and toxicity data. Bioelectromagnetics 24(7):524-527.
30. Shupak NM, Hensel JM, Cross-Mellor SK, Kavaliers M, Prato FS, Thomas AW. 2004. Analgesic and behavioral effects of a 100 μT specific pulsed extremely low frequency magnetic field on control and morphine treated CF-1 mice. Neurosci Lett 354:30-33.
31. Shupak NM, McKay JC, Nielson WR, Rollman GB, Prato FS, Thomas AW. 2006. Exposure to a specific pulsed low-frequency magnetic field: A double-blind placebo-controlled study of effects on pain ratings in rheumatoid arthritis and fibromyalgia patients. Pain Res Manage 11(2): 85-90.
32. Smania N, Corato E, Fiaschi A, Pietropoli P, Aglioti SM, Tinazzi M. 2003. Therapeutic effects of peripheral repetitive magnetic stimulation on myofascial pain syndrome. Clin Neurophysiol 114(2):350-358.
33. Smith EM. 2003. Opioid peptides in immune cells. Adv Exp Med Biol 521:51-68.
34. Thomas AW, Kavaliers M, Prato FS, Ossenkopp KP. 1997a. Antinociceptive effects of pulsed magnetic field in the land snail, Capaea nemoralis. Life Sci 222:107-110.
35. Thomas AW, Kavaliers M, Prato FS, Ossenkopp KP. 1997b. Pulsed magnetic field induced "analgesia" in the land snail, Cepaea nemoralis, and the effects of μ-, δ- and κ-opioid receptor agonists/antagonists. Peptides 18(5):703-709.
36. Weinberger A, Nyska A, Giler S. 1996. Treatment of experimental inflammatory synovitis with continuous magnetic field. Isr J Med Sci 32(12):1197-1201.
37. Wende VC, Margoli S. 1956. Analgesic test based upon experimentally induced acute abdominal pain in rats. Fed Proc 15:494.
38. Witkin LB, Heuter CF, Galdi F, O'Keefe E, Spitaletta P, Plummer AJ. 1961. Pharmacology of 2-amino-indane hydrochloride (Su-8629), a potent non-narcotic analgesic. J Pharmacol Exp Ther 133:400-408.
39. Yaksh TL. 1999. Spinal systems and pain processing: Development of novel analgesic drugs with mechanistically defined models. TiPS 20:329-337.
40. Zadina JE, Hackler L, Le GJ, Kastin AJ. 1997. A potent and selective endogenous agonist for the μ opiate receptor. Nature 386:499-502.
41. Zimmermann M. 1983. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16:109-110.